Illumina, Inc. last reported quarterly results on Oct 29, 2026, for Q3 FY2026 (the quarter ended Sep 27, 2026): revenue of $1.1 billion (+4.2% year over year) and diluted EPS of $1.43. It usually reports 16–32 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 12, 2027.
Results for Q4 FY2026, the quarter ending around Dec 27, 2026. Expected on a Tuesday. Based on last year's release for the same quarter on Jan 13, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 16–32 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 29, 2026
32 days after quarter end
|
Q3 FY2026
ended Sep 27, 2026
|
1,129
+4.2%
|
220
+46.7%
|
1.43
+45.9%
|
|
Jul 30, 2026
32 days after quarter end
|
Q2 FY2026
ended Jun 28, 2026
|
1,159
+9.4%
|
207
-11.9%
|
1.35
-9.4%
|
|
Apr 30, 2026
32 days after quarter end
|
Q1 FY2026
ended Mar 29, 2026
|
1,091
+4.8%
|
134
+2.3%
|
0.87
+6.1%
|
|
Jan 13, 2026
16 days after quarter end
|
Q4 FY2025
ended Dec 28, 2025
|
1,159
+5.0%
|
334
+79.6%
|
2.18
+86.6%
|
|
Oct 30, 2025
32 days after quarter end
|
Q3 FY2025
ended Sep 28, 2025
|
1,084
+0.4%
|
150
-78.7%
|
0.98
-77.8%
|
|
Jul 31, 2025
32 days after quarter end
|
Q2 FY2025
ended Jun 29, 2025
|
1,059
-4.8%
|
235
+111.8%
|
1.49
+111.9%
|
|
May 8, 2025
39 days after quarter end
|
Q1 FY2025
ended Mar 30, 2025
|
1,041
-3.3%
|
131
+204.0%
|
0.82
+203.8%
|
|
Jan 14, 2025
16 days after quarter end
|
Q4 FY2024
ended Dec 29, 2024
|
1,104
-1.6%
|
186
+205.7%
|
1.17
+205.0%
|
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- ILMN (Nasdaq)
- Fiscal year ends
- January 3
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1110803
- Former names
- ILLUMINA INC (until Aug 19, 2019)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
- 10x Genomics, Inc. TXG
Source: SEC EDGAR filings. This is company-reported data, not investment advice.